Peripheral Blood Stem Cell TransplantationBone Marrow TransplantationHematopoietic Stem Cell TransplantationTransplantation, HomologousTransplantation, AutologousGraft vs Host DiseaseStem Cell TransplantationTransplantation ConditioningBone MarrowHematologic NeoplasmsHematopoietic Stem Cell MobilizationBone Marrow CellsGraft SurvivalTransplantation ChimeraHematopoietic Stem CellsGranulocyte Colony-Stimulating FactorStem CellsBusulfanWhole-Body IrradiationCombined Modality TherapyTissue DonorsLeukapheresisMelphalanCyclophosphamideAntigens, CD34Treatment OutcomeRecurrenceLeukemiaMultiple MyelomaHistocompatibility TestingHistocompatibilityRemission InductionCord Blood Stem Cell TransplantationBlood Component RemovalAntineoplastic Combined Chemotherapy ProtocolsMyeloablative AgonistsAnemia, AplasticLiver TransplantationTransplantation, IsogeneicLymphoma, Non-HodgkinImmunosuppressive AgentsHematopoiesisLeukemia, Myeloid, AcuteRetrospective StudiesLeukemia, Myelogenous, Chronic, BCR-ABL PositiveGraft vs Leukemia EffectTime FactorsBone and BonesEtoposideDisease-Free SurvivalSurvival AnalysisBone Marrow PurgingLymphocyte DepletionSurvival RateMyelodysplastic SyndromesPrecursor Cell Lymphoblastic Leukemia-LymphomaAntineoplastic Agents, AlkylatingInfectionBone Marrow DiseasesCytarabineKidney TransplantationSalvage TherapyGraft vs Tumor EffectCytomegalovirus InfectionsImmunosuppressionVidarabineThiotepaHematologic DiseasesTransplantation ImmunologyHLA AntigensCarmustineHodgkin DiseaseMesenchymal Stem Cell TransplantationT-LymphocytesCyclosporineBlood CellsAcute DiseaseFollow-Up StudiesLeukocyte TransfusionLymphocyte TransfusionLymphomaFatal OutcomeHepatic Veno-Occlusive DiseaseVincristineCell TransplantationMice, Inbred C57BLGraft RejectionPOEMS SyndromeCell DifferentiationLeukemia, MyeloidPlatelet CountAmyloidosisImmunophenotypingFlow CytometryRadiation ChimeraOpportunistic InfectionsNuclear FamilyBlood Cell CountPrognosisHeart Transplantation